HEALTHCARE-ASSOCIATED INFECTIONS AND MICROBIOLOGICAL ANALYSIS AT THE CLINIC FOR ANESTHESIA AND INTENSIVE THERAPY IN A TERTIARY HEALTH INSTITUTION DURING A ONE-YEAR PERIOD

  • Milena Stojanovic UKC Nis
Ključne reči: healthcare-associated infection, nosocomial, bacteria, antibiotic

Sažetak


The term Healthcare-Associated Infections (HAI) or Nosocomial Infections (NI) refers to infections that occur in patients during their stay and treatment in medical conditions, but were not present at the time of admission and that manifest at least 48 h after hospital admission. HAIs are more frequent in developing countries (5.7–19.1%) than in developed ones (3.5–12%). Antimicrobial resistance is one of the global health problems with a significant burden, and it is an inevitable consequence of using antimicrobial drugs. The unjustified use of antibiotics has contributed to antimicrobial resistance and changes in the causative pathogens responsible for HAIs. These types of infections prolong the length of hospital stay, lead to long-term disability, and increase morbidity and mortality. The most common types of HAIs are: Ventilator-Associated Pneumonia (VAP), Central Line-Associated Bloodstream Infections (CLABSI), Catheter-Associated Urinary Tract Infections (CAUT) and Surgical Site Infections (SSI).

This study aimed to determine the most common bacteria causes of HAIs as well as the distribution according to the type of isolated bacteria from different types of samples.

The retrospective study was conducted at the Clinic for Anesthesia and Intensive Therapy, University Clinical Center Niš, during the period from January to December 2024. The patient samples were obtained, namely: blood, groin swab, oral cavity swab, wound swab, rectum swab, armpit swab, urine, aspirate from the endotracheal tube, nose swab, drain content, abdominal cavity content, tip of the central venous catheter, tip of the drain and aspirate from bronchia. The material was sent to the local microbiological laboratory with the aim of obtaining a biogram and antibiogram.

Depending on the type of bacteria, the distribution was as follows: Klebsiella spp. (20.15%), Enterococcus faecalis (19.26%), Acinetobacter spp. (14.41%), Pseudomonasaeruginosa (7.9%), Escherichia coli (7.17%), Staphylococcus epidermidis (4.99%), Proteus mirabilis (3.96%), Enterococcus faecium (2.94%), Enterobacter spp. (2.94%) and Staphylococcus spp. (2.19%). Klebsiella spp. was the dominant bacterium isolated from oral cavity swab (3.28%), Enterococcus faecium from groin swab (5.60%), Acinetobacter spp. from endotracheal aspirate (1.91%), Pseudomonas aeruginosa from wound swab (2.25%) and Escherichia coli from rectal swab (1.84%).

Healthcare-associated infections have a significant negative impact on hospitalized patients. They lead to permanent disability, prolonged patients’ length of stay and increased mortality as well as expenditure and waste of medical resources. The predominance of microorganisms depends both on the hospital conditions, as well as on the patients and antibiotics prescribed by physicians. It is recommended to establish a precise schedule for antibiotic use in each region based on the most common pathogens and antibiotic resistance patterns, and surveillance programs as important tools which would be helpful to clinicians to choose the most appropriate antimicrobial therapy for hospitalized patients. 

Reference

Aitken CJD. Nosocomial spread of viral disease. Clin Microbiol Rev 2001; 14(3): 528-46.[CrossRef][PubMed]

American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 71:388–416. [CrossRef][PubMed]

Anderson DJ. Surgical site infections. Infect Dis Clin North Am 2011; 25(1): 135-53.[CrossRef][PubMed]

Asokan GV, Ramdahan T, Ahmed E, Sanad H. WHO global priority pathogens list: a bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in bahrain. Oman Med J 2019;34 (3): 184–93.[CrossRef][PubMed]

Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 2022;70:103227. [CrossRef][PubMed]

CDC. Urinary tract infection (catheter-associated urinary tract infection [CAUTI] and non-catheter associated urinary tract infection [UTI]) and other urinary system infection [USI]) events. Atlanta, Georgia: CDC; 2016. [Online] Available from: http:// www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.pdf

Centers for Disease Control and Prevention (CDC).Vital signs: Central line–associated blood stream infections – United States, 2001, 2008, and 2009. Morb Mortal Wkly Rep 2011; 60(08): 243-8. [PubMed]

Christaki E, Marcou M, Tofarides A. Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence. J Mol Evol 2020; 88 (1): 26–40. [CrossRef][PubMed]

Custodio HT. Medscape: hospital-acquired infections, 2014. Available at: http://emedicine.medscape.com/article/967022- overview. Accessed 12 October 2014

Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN. The microbiology of bloodstream infection: 20- year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 2019;63(7):19. e00355. [CrossRef][PubMed]

Dowell S, Marcy S, Phllips W, Gerber M, Scwartz B. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 1998;101(suppl):163-84. [CrossRef]

Ducel JF, Nicolle L. Prevention of hospital-acquired infections. Geneva: WHO; 2002.

Friedrich AW. Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go Wien Med Wochenschr 2019; 169(suppl1):25– 30. [CrossRef][PubMed]

Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-40. [CrossRef][PubMed]

Gastmeier P, Kampf G, Wischnewski N, Schumacher M, Daschner F, Ruden H. Importance of the surveillance method various national prevalence studies on nosocomial infections and limits of comparison. Infect Control Hosp Epidemiol 1998; 19: 661–7.[CrossRef][PubMed]

George P, Sequiera, A. Antimicrobial sensitivity pattern among organisms isolated from the endotracheal aspirates of patients with ventilator associated pneumonia. J Clin Diag Res 2010;4: 3397-401.

Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54(4):258-66.[CrossRef][PubMed]

Hunter JD. Ventilator associated pneumonia. BMJ 2012; 344: 40-4. [CrossRef][PubMed]

Jain P, Parada J, David A, Smith L. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med 1995; 155: 1425–9.[CrossRef][PubMed]

Joshi SG, Litake GM. Acinetobacter baumannii: An emerging pathogenic threat to public health. World J Clin Infect Dis 2013; 3(3): 25-36. [CrossRef] [PubMed]

Joshi SG, Litake GM. Acinetobacter baumannii: An emerging pathogenic threat to public health. World J Clin Infect Dis 2013; 3(3): 25-36. [CrossRef] [PubMed]

Khan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed 2017; 7(5): 478–82.[CrossRef]

Klevens RM, Edwards JR, Richards CL Jr. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007;122(2):160-6. [CrossRef][PubMed]

Kollef MH, Torres A, Shorr AF, Martin-Loeches I, Micek ST. Nosocomial infection. Criti Care Med2021; 49:169–87. [CrossRef][PubMed]

Kumar AV, Pillai VS, Dinesh KR, Karim S. The phenotypic detection of Carbapenemase in meropenem resistant Acinetobacter calcoaceticus baumannii complex in a tertiary care hospital in south India. J Clin Diagn Res. 2011;5(2):223-6.

Monegro AF, Muppidi V, Regunath H. Hospital Acquired Infections. Treasure Island, FL: Stat Pearls Publishing 2022.[PubMed]

Nouri F, Karami P, Zarei O, Kosari F, Alikhani MY, Zandkarimi E, ZarandiER, Taheri M. Prevalence of Common Nosocomial Infections and Evaluation of Antibiotic Resistance Patterns in Patients with Secondary Infections in Hamadan, Iran. Infect Drug Resist 2020; 15:13:2365-74. [CrossRef][PubMed]

Owens CD. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 2008; 70(Suppl 2): 3-10. [CrossRef][PubMed]

Percival SP, Suleman L, Vuotto C. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. Journal of Medical Microbiology 2015; 64: 323–34. [CrossRef][PubMed]

Prevention of hospital-acquired infections. A practical guide 2nd edition. World Health Organization Department of Communicable Disease, Surveillance and Response. 2002. Available at: http://www.who.int/csr/resources/publications/whoc dscsreph200212.pdf.

Singh PK. Antibiotics, handle with care. Geneva: WHO; 2016. [Online] Available from: http://www.searo.who.int/mediacentre/ releases/2015/antibiotics-awareness-week-2015/en/

Steven M, Koenig JDT. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 2006; 19(4): 637-57.[CrossRef][PubMed]

Tabak YP, Vankeepuram L, YeG, Jeffers K, Gupta V, Murray PR. Blood culture turnaround time in U.S. acute care hospitals and implications for laboratory process optimization. J. Clin. Microbiol. 2018; 56: e00500–18. [CrossRef][PubMed]

Vincent JL, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302(21): 2323-9. [CrossRef][PubMed]

Wei-Chih Liao, Wei-Sheng Chung, Ying-Chieh Lo, Wen-Hsin Shih , Chia-Hui Chou, et al. Changing epidemiology and prognosis of nosocomial bloodstream infection: A singlc enter retrospective study in Taiwan Journal of Microbiology, Immunology and Infection 2022;55(6): 1293-300. [CrossRef][PubMed]

WHO. Antimicrobial resistance. Geneva: WHO; 2014. [Online] Available from: http://www.searo.who.int/thailand/factsheets/ fs0023/en/

WHO. Preventing bloodstream infections from central line venous catheters. Geneva: WHO; 2016. [Online] Available from: http:// www.who.int/patientsafety/implementation/bsi/en/

WHO. The burden of health care-associated infection worldwide. 2016 [Online] Available from: http://www.who.int/gpsc/country_ work/burden_hcai/en/

WHO. WHO's first global report on antibiotic resistance reveals serious, worldwide threat to public health. Geneva: WHO; 2014.

World Health Organization. Healthcare-associated infections: fact sheet, 2014. Available at: http://www.who.int/gpsc/country_work/gpsc_ccisc_ fact_sheet_en.pdf.

Objavljeno
2026/06/17
Rubrika
Originalni rad